16-30 of 379
Qihua Fan, MD
Patterns of Progression and Resistance in ALK+ mNSCLC
Project Oncology®Patterns of Progression and Resistance in ALK+ mNSCLC
Alice T. Shaw, MD, PhD
Guiding mNSCLC Treatment After ALK-TKI Progression
Project Oncology®Guiding mNSCLC Treatment After ALK-TKI Progression
Alice T. Shaw, MD, PhD
Investigating Unanswered Questions in ALK+ mNSCLC Care
Project Oncology®Investigating Unanswered Questions in ALK+ mNSCLC Care
Alice T. Shaw, MD, PhD
More Than a Myopathy: The Lived Experience of TK2d
NeuroFrontiersMore Than a Myopathy: The Lived Experience of TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
NeuroFrontiersOutcome Measures Capture Progression in Late-Onset TK2d
- advertisement
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
AudioAbstractsUntreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
Sotatercept in PAH: Safety Signals from Real-World Data
Clinician's RoundtableSotatercept in PAH: Safety Signals from Real-World Data
Parth Rali, MD
Comparing CAR T-Cell Therapies for R/R Multiple Myeloma
Project Oncology®Comparing CAR T-Cell Therapies for R/R Multiple Myeloma
Charles Turck, PharmD, BCPS, BCCCP
Krina Patel, MD, MSc
CAR T-Cell vs Bispecific Therapies for R/R Multiple Myeloma: How They Compare
Project Oncology®CAR T-Cell vs Bispecific Therapies for R/R Multiple Myeloma: How They Compare
Charles Turck, PharmD, BCPS, BCCCP
Krina Patel, MD, MSc
A Multidisciplinary Approach to Vulvar Lichen Sclerosus Care
DermConsultA Multidisciplinary Approach to Vulvar Lichen Sclerosus Care
Charles Turck, PharmD, BCPS, BCCCP
Christina Kraus, MD
Jill Krapf, MD
Heart Transplant in ATTR-CM: A New Look at Referral and Candidacy
On the Frontlines of ATTR-CMHeart Transplant in ATTR-CM: A New Look at Referral and Candidacy
Steve Jackson, PharmD
Alex Reyentovich, MD
- advertisement
Recognizing Telomere Biology Disorders in Familial Pulmonary Fibrosis
Clinician's RoundtableRecognizing Telomere Biology Disorders in Familial Pulmonary Fibrosis
Pilar Rivera-Ortega, MD
Precision Medicine in Fibrotic ILD: Predicting Risk and Treatment Response
Clinician's RoundtablePrecision Medicine in Fibrotic ILD: Predicting Risk and Treatment Response
Pilar Rivera-Ortega, MD
Targeting Pseudomonas aeruginosa in Bronchiectasis: Phase 2a Findings
Clinician's RoundtableTargeting Pseudomonas aeruginosa in Bronchiectasis: Phase 2a Findings
Colm Leonard, MD
